Medtronic Management

Management criteria checks 4/4

Medtronic's CEO is Geoff Martha, appointed in Apr 2020, has a tenure of 4.42 years. total yearly compensation is $15.39M, comprised of 8.8% salary and 91.2% bonuses, including company stock and options. directly owns 0.004% of the company’s shares, worth $4.47M. The average tenure of the management team and the board of directors is 3.3 years and 9.3 years respectively.

Key information

Geoff Martha

Chief executive officer

US$15.4m

Total compensation

CEO salary percentage8.8%
CEO tenure4yrs
CEO ownership0.004%
Management average tenure3.3yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: The Tide Is Turning

Aug 24

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Aug 21
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: Dark Clouds Are Clearing - Outperformance Ahead

Aug 14

Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Aug 11
Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth

Jul 15

Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Jul 09
Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Is Medtronic (NYSE:MDT) A Risky Investment?

Jun 21
Is Medtronic (NYSE:MDT) A Risky Investment?

Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter

Jun 21

Is Medtronic's Dividend In A Good Place?

Jun 14

Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Jun 03
Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Medtronic: Solid Q4 Earnings, Don't Fret About Guidance

May 26

Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

May 04
Investors Met With Slowing Returns on Capital At Medtronic (NYSE:MDT)

Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Mar 10
Does This Valuation Of Medtronic plc (NYSE:MDT) Imply Investors Are Overpaying?

Where Will Medtronic Stock Be In 4 Years?

Feb 17

Medtronic: A Trend Change May Be Underway Ahead Of Earnings

Feb 06

Medtronic recalls ~23K Mahurkar hemodialysis catheters

Jan 30

CEO Compensation Analysis

How has Geoff Martha's remuneration changed compared to Medtronic's earnings?
DateTotal CompensationSalaryCompany Earnings
Jan 26 2024n/an/a

US$4b

Oct 27 2023n/an/a

US$4b

Jul 28 2023n/an/a

US$4b

Apr 28 2023US$15mUS$1m

US$4b

Jan 27 2023n/an/a

US$4b

Oct 28 2022n/an/a

US$4b

Jul 29 2022n/an/a

US$5b

Apr 29 2022n/an/a

US$5b

Jan 28 2022n/an/a

US$5b

Oct 29 2021n/an/a

US$5b

Jul 30 2021n/an/a

US$4b

Apr 30 2021US$18mUS$1m

US$4b

Jan 29 2021n/an/a

US$3b

Oct 30 2020n/an/a

US$4b

Jul 31 2020n/an/a

US$4b

Apr 24 2020US$6mUS$905k

US$5b

Jan 24 2020n/an/a

US$5b

Oct 25 2019n/an/a

US$5b

Jul 26 2019n/an/a

US$4b

Apr 26 2019US$4mUS$693k

US$5b

Compensation vs Market: Geoff's total compensation ($USD15.39M) is about average for companies of similar size in the US market ($USD13.51M).

Compensation vs Earnings: Geoff's compensation has been consistent with company performance over the past year.


CEO

Geoff Martha (53 yo)

4yrs

Tenure

US$15,394,632

Compensation

Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Chairman at Medtron...


Leadership Team

NamePositionTenureCompensationOwnership
Geoffrey Martha
Chairman of the Board & CEO4yrsUS$15.39m0.0042%
$ 4.5m
Karen Parkhill
Executive VP & CFO7.8yrsUS$6.12m0.0050%
$ 5.4m
Sean Salmon
Executive VP & President of Cardiovascular Portfoliono dataUS$5.36m0.0019%
$ 2.0m
Robert J. ten Hoedt
Executive VP & President of Global Regions9.3yrsUS$5.05m0.0024%
$ 2.5m
Mark Ploof
Senior Vice President of Global Operations and Business Services7.5yrsno datano data
Jennifer Kirk
Senior VP2.8yrsno data0.00099%
$ 1.1m
Kenneth Washington
Senior VP and Chief Technology & Innovation Officerless than a yearno datano data
Laura Mauri
Senior VP and Chief Scientific2yrsno datano data
Ryan Weispfenning
VP & Head of Investor Relations8.8yrsno datano data
Ivan Fong
Executive VP2.2yrsUS$11.72m0.00082%
$ 877.3k
Torod Neptune
Senior VP & Chief Communications Officer3.3yrsno datano data
Matt Walter
Chief Human Resources Officerless than a yearno datano data

3.3yrs

Average Tenure

58yo

Average Age

Experienced Management: MDT's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Geoffrey Martha
Chairman of the Board & CEO4.4yrsUS$15.39m0.0042%
$ 4.5m
Scott Donnelly
Independent Director11.3yrsUS$365.01k0.00099%
$ 1.1m
Kendall Powell
Independent Director17.3yrsUS$350.01k0.0013%
$ 1.4m
Randall Hogan
Independent Director9.3yrsUS$385.01k0.0031%
$ 3.3m
Craig Arnold
Lead Independent Director9.3yrsUS$410.01k0.0026%
$ 2.8m
Denise O'Leary
Independent Director24.3yrsUS$375.01k0.0028%
$ 3.0m
Andrea Goldsmith
Independent Director5.1yrsUS$370.01k0.00033%
$ 353.0k
Elizabeth Nabel
Independent Director10.3yrsUS$370.01k0.00088%
$ 941.4k
Lidia Fonseca
Independent Director1.8yrsUS$294.37kno data
Kevin Lofton
Independent Director3.6yrsUS$370.01k0.00017%
$ 181.9k
Gregory Lewis
Independent Directorless than a yearno datano data

9.3yrs

Average Tenure

63yo

Average Age

Experienced Board: MDT's board of directors are considered experienced (9.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.